Kathryne E. Marks
@kb-phd.bsky.social
Reposted by Kathryne E. Marks
Immune checkpoint inhibitor therapies for cancer can induce unintended immune related adverse events (irAEs).
Here, Deepak A. Rao & team identify T cell features in pre-treatment blood samples that are associated with irAEs after ICI therapy: doi.org/10.1172/jci....
Here, Deepak A. Rao & team identify T cell features in pre-treatment blood samples that are associated with irAEs after ICI therapy: doi.org/10.1172/jci....
January 28, 2026 at 1:02 PM
Immune checkpoint inhibitor therapies for cancer can induce unintended immune related adverse events (irAEs).
Here, Deepak A. Rao & team identify T cell features in pre-treatment blood samples that are associated with irAEs after ICI therapy: doi.org/10.1172/jci....
Here, Deepak A. Rao & team identify T cell features in pre-treatment blood samples that are associated with irAEs after ICI therapy: doi.org/10.1172/jci....